Lower respiratory tract infections in elderly patients with asthma

Immunology and Allergy Clinics of North America

Volumn 17, Issue 4, 1997, Pages 671-700

  Hunter, Alan J ^a   Bryant, Richard E ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 2642639692     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8561(05)70337-4     Document Type: Article

References (196)

1. Abernathy-Carver KJ, Fan LL, Boguniewicz M, et al: Legionella and Pneumocystis pneumonia in asthmatic children on high doses of systemic steroids. Pediatr Pulmonol 18:135-138, 1994
2. Abramson JS, Giebink GS, Quie PG: Influenza A virus-induced polymorphonuclear leukocyte dysfunction in the pathogenesis of experimental pneumococcal otitis media. Infect Immun 36:289-296, 1989
3. Al-Nakib W, Higgins PG, Barrow I, et al: Prophylaxis and treatment of rhinovirus colds with zinc gluconate lozenges. J Antimicrob Chemother 20:893-901, 1987
4. Albazzaz MK, Pal C, Berman P, et al: Inflammatory markers of lower respiratory tract infection in elderly people. Age Ageing 23:299-302, 1994
5. Allegra L, Blasi F, Centanni S, et al: Acute exacerbations of asthma in adults: Role of Chlamydia pneumoniae in infection. Eur Respir J 7:2165-2168, 1994
6. Appelbaum PC: Epidemiology and in vitro susceptibility of drug-resistant streptococcus pneumoniae. Pediatr Infect Dis J 15:932-939, 1996
7. Backman KS, Roberts M, Patterson R: Allergic bronchopulmonary mycosis caused by Fusarium vasinfectum. Am J Respir Crit Care Med 152:1379-1381, 1995
8. Banerjee DK, Lee GS, Malik SK, et al: Underdiagnosis of asthma in the elderly. Br J Dis Chest 81:23-29, 1987
9. Bartlett JG, Mundy LM: Community-acquired pneumonia. N Engl J Med 333:1618-1624, 1995
10. Bateman JR, Pavia D, Sheahan NF, et al: Impaired tracheobronchial clearance in patients with mild stable asthma. Thorax 38:463-467, 1983
11. Beasley R, Coleman ED, Hermon Y, et al: Viral respiratory tract infection and exacerbations of asthma in adult patients. Thorax 43:679-683, 1988
12. Bender BS, Nagel JE, Adler WH, et al: Absolute peripheral blood lymphocyte count and subsequent mortality of elderly men. J Am Geriatr Soc 34:649-654, 1986
13. Berkovich S, Millian SJ, Snyder RD: The association of viral and mycoplasma infections with recurrence of wheezing in the asthmatic child. Ann Allergy 28:43-49, 1970
14. Berman SZ, Mathison DA, Stevenson DD, et al: Transtracheal aspiration studies in asthmatic patients in relapse with "infective" asthma and in subjects without respiratory disease. J Allergy Clin Immunol 56:206-214, 1975
15. Beveridge RC, Grunfeld AF, Hodder RV, et al: Guidelines for the emergency management of asthma in adults. Can Med Assoc J 155:25-37, 1996
16. Bjuggren G, Kraepelien S, Lind J: Sinusitis in children at home and in day-nurseries. Ann Paediatr 173:205-221, 1949
17. Black ER, Mushlin AI, Griner PF, et al: Predicting the need for hospitalization of ambulatory patients with pneumonia. J Gen Intern Med 6:394-400, 1991
18. Braman SS: Asthma in the elderly patient. Clin Chest Med 14:413-422, 1993
19. Braman SS, Kaemmerlen JT, Davis SM: Asthma in the elderly: A comparison between patients with recently acquired and long-standing disease. Am Rev Respir Dis 143:336, 1991
20. British Thoracic Society and the Public Health Laboratory Service: Community-acquired pneumonia in adults in British hospitals in 1982-1983: A survey of aetiology, mortality, prognostic factors and outcome. QJM 62:195-220, 1987
21. Broder I, Higgins MW, Mathews KP, et al: Epidemiology of asthma and allergic rhinitis in a total community, Tecumseh, Michigan: III. Second survey of the community. J Allergy Clin Immunol 53:127, 1974
22. Broder I, Higgins MW, Mathews KP, et al: Epidemiology of asthma and allergic rhinitis in a total community, Tecumseh, Michigan: IV. Natural History. J Allergy Clin Immunol 54:100, 1974
23. Bryant RE: Viral pneumonia. In Braude A, Davis C, Flere J (eds): Infectious Disease and Microbiology, ed 2, Philadelphia, WB Saunders Co, 1986
24. Busse WW, Swenson CA, Borden EC, et al: Effect of influenza A virus on leukocyte histamine release. J Allergy Clin Immunol 71:382-388, 1983
25. Camner P, Jarstrand C, Philipson K: Transbronchial clearance in patients with influenza. Am Rev Respir Dis 108:131-135, 1973
26. Carlsen KH, Ørstavik I, Leegaard J, et al: Respiratory virus infections and aeroallergens in acute bronchial asthma. Arch Dis Child 59:310-315, 1984
27. Carson JL, Collier AM, Hu SS, et al: Acquired ciliary defects in the nasal epithelium of children with acute viral upper respiratory tract infections. N Engl J Med 312:463-468, 1985
28. Cassel CK: In Cassel CK, Cohen HJ, Larson EB, et al: Geriatric Medicine, ed 3. New York, Springer-Verlag, 1997, pp xi-xiii
29. Centers for Disease Control: Pneumonia and influenza death rates-United States, 1979-1994. MMWR Morb Mortal Wkly Rep 44:535-537, 1995
30. Chandra RK: Nutritional regulation of immunity and risk of infection in old age. Immunology 67:141-147, 1989
31. Chandra RK, Joshi P, Au B, et al: Nutrition and immunocompetence of the elderly. Effect of short-term nutritional supplementation on cell-mediated immunity and lymphocyte subsets. Nutr Res 2:223-232, 1982
32. Choong K, Zwaigenbaum L, Onyett H: Severe varicella after low dose inhaled corticosteroids. Pediatr Infect Dis J 14:809-811, 1995
33. Cimolai N, Wensley D, Sear M, et al: Mycoplasma as a cofactor in severe respiratory infections. Clin Infect Dis 21:1182-1185, 1995
34. Connolly MJ, Crawley JJ, Charan NB, et al: Reduced subjective awareness of bronchoconstriction provoked by methacholine in elderly asthmatic and normal subjects as measured on a simple awareness scale. Thorax 47:410-413, 1992
35. Crean JM, Niederman MS, Fein AM, et al: Rapidly progressive respiratory failure due to Aspergillus pneumonia: A complication of short-term corticosteroid therapy. Crit Care Med 20:148-150, 1992
36. Crossley KB, Peterson PK: Infections in the elderly. In Mandell GL, Bennet JE, Dolin R (eds): Principles and Practices of Infectious Diseases, ed 4. New York, Churchill-Livingstone, 1995, pp 2737-2742
37. Daley J, Jencks S, Draper D, et al: Predicting hospital-associated mortality for medicare patients: A method for patients with stroke, pneumonia, acute myocardial infarction, and congestive heart failure. JAMA 260:3617-3624, 1988
38. Denning DS, VanWye JD, Lewiston NJ, et al: Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole. Chest 100:813-819, 1991
39. Dodge RR, Burrows B: The prevalence and incidence of asthma and asthma-like symptoms in a general population sample. Am Rev Respir Dis 122:567-575, 1980
40. Douglas RM, Miles HM, Moore BW, et al: Failure of effervescent zinc acetate lozenges to alter the course of upper respiratory tract infection in Australian adults. Antimicrob Agents Chemother 31:1263-1265, 1987
41. Drach FS, Bryant RE: Spotting the pneumococcus in today's pneumonia milieu. J Respir Dis 14:198-216, 1993
42. Duchateau J, Delepesse G, Vrijens R, et al: Beneficial effects of oral zinc supplementation on immune response of old people. Am J Med 70:1001-1004, 1981
43. Eby GA, Davis DR, Halcomb WW: Reduction in duration of common cold by zinc gluconate lozenges in a double-blind study. Antimicrob Agents Chemother 25:20-24, 1984
44. Empey DW, Laitinen LA, Jacobs L, et al: Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infections. Am Rev Respir Dis 113:131-139, 1976
45. Enright PL, Kronmal RA, Higgins MW, et al: Prevalence and correlates of respiratory symptoms and disease in the elderly. Chest 106:827-834, 1994
46. Esposito AL: Community-acquired bacteremic pneumococcal pneumonia: Effect of age on manifestations and outcome. Arch Intern Med 144:945-948, 1984
47. Evans FO Jr, Sydnor JB, Moore WEC, et al: Sinusitis of the maxillary antrum. N Engl J Med 293:735-739, 1975
48. Evans R, Mullally DI, Wilson RW, et al: National trends in the morbidity and mortality of asthma in the US. Chest 91:655-745, 1987
49. Falsey AR, Cunningham CK, Barker WH, et al: Respiratory syncytial virus and influenza A infections in hospitalized elderly. J Infect Dis 172:389-394, 1995
50. Falsey AR, McCann RM, Hall WJ, et al: Acute respiratory tract infection in daycare centers for older persons. J Am Geriatr Soc 43:30-36, 1995
51. Fang G, Fine MJ, Orloff J, et al: New and emerging etiologies for community-acquired pneumonia with implications for therapy. Medicine 69:307-316, 1990
52. Farr BM: Prognosis and decisions in pneumonia. N Engl J Med 336:288-289, 1997
53. Farr BM, Conner EM, Betts RF, et al: Two randomized controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus colds. Antimicrob Agents Chemother 31:1183-1187, 1987
54. Farr BM, Sloman AJ, Fisch MJ: Predicting death in patients hospitalized for community-acquired pneumonia. Ann Intern Med 115:428-436, 1991
55. Fedson DS, Shapiro ED, LaForce FM, et al: Pneumococcal vaccine after 15 years of use: Another view. Arch Intern Med 154:2531-2535, 1994
56. Fernandes C, Nair M, Onoe K, et al: Improvement of cell-mediated immunity functions by dietary zinc deficiency in mice. Proc Natl Acad Sci USA 76:457-461, 1979
57. File TM, Segreti J, Dunbar L, et al: A multicenter randomized study comparing the efficacy and safety of IV/PO levafloxacin vs ceftriaxone/cefuroxime axetil in the treatment of adults with community acquired pneumonia [abstract]. Am Soc Microbiol 1:280, 1996
58. Fine MJ, Auble TE, Yealy DM, et al: A prediction rule to identify low risk patients with community-acquired pneumonia. N Engl J Med 336:243-250, 1997
59. Fine MJ, Hough LJ, Medsger AR, et al: The hospital admission decision for patients with community-acquired pneumonia: Results from the pneumonia patient outcomes research team cohort study. Arch Intern Med 157:36-44, 1997
60. Fine MJ, Singer DE, Hanusa BH, et al: Validation of a pneumonia prognostic index using the MedisGroups comparative hospital database. Am J Med 94:153-159, 1993
61. Fine MJ, Smith DN, Singer DE: Hospitalization decision in patients with community-acquired pneumonia: A prospective cohort study. Am J Med 89:713-721, 1990
62. Fine MJ, Smith MA, Carson CA, et al: Prognosis and outcomes of patients with community-acquired pneumonia. JAMA 274:134-141, 1996
63. Fink MP, Snydman DR, Niederman MS, et al: Treatment of severe pneumonia in hospitalized patients: Results of a multicenter randomized double blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. Antimicrob Agents Chemother 38:547-557, 1994
64. Fraker PJ, De Pasquale-Jardieu P, Zwick CM, et al: Regeneration of T cell helper function in zinc deficient adult mice. Proc Natl Acad Sci USA 75:5660-5664, 1978
65. Frick OL, German DF, Mills J: Development of allergy in children. I. Association with virus infections. J Allergy Clin Immunol 63:228-241, 1979
66. Fumer SE, Brody JA, Jankowski LM: Epidemiology and aging. In Cassel CK, Cohen HJ, Larson EB, et al: Geriatric Medicine, ed 3. New York, Springer-Verlag, 1997, pp 37-43
67. Germaud P, Tuchats E: Allergic bronchopulmonary aspergillosis treated with itraconazole. Chest 107:883, 1995
68. Gem JC, Vetis R, Kelly EA, et al: Rhinovirus produces non-specific activation of lymphocytes through a monocyte dependent mechanism. J Immunol 157:1605-1612, 1996
69. Giebink GS: The microbiology of otitis media. Pediatr Infect Dis J 8:S18-S20, 1989
70. Gil JC, Cedillo RL, Mayagoitia BG, et al: Isolation of Mycoplasma pneumoniae from asthmatic patients. Ann Allergy 70:23-25, 1993
71. Godfrey JC, Conant-Sloane B, Smith DS, et al: Zinc gluconate and the common cold: A controlled clinical study. J Intern Med Res 20:234-246, 1992
72. Granton JT, Grossman RF: Community-acquired pneumonia in the elderly patient. Clin Chest Med 14:537-553, 1993
73. Grayston JT: Chlamydia pneumoniae, strain TWAR. Chest 95:664-669, 1989
74. Grayston JT: Chlamydia pneumoniae (TWAR). In Mandell GL, Bennet JE, Dolin R (eds): Principles and Practices of Infectious Diseases, ed 4. New York, Churchill-Livingstone, 1995, p 1698
75. Gregg I: Provocation of airflow limitation by viral infection: Implication for treatment. Eur J Respir Dis (suppl):369-379, 1983
76. Gwaltney JM: Acute community-acquired sinusitis. Clin Infect Dis 23:1209-1225, 1996
77. Gyetko MR, Toews GB: Immunology of the aging lung. Clin Chest Med 14:379-391, 1993
78. Haas DW, Stratton CW, Griffin JP, et al: Diminished activity of ceftizoxime in comparison to cefotaxime and ceftriaxone against Streptococcus pneumoniae. Clin Infect Dis 20:671-676, 1995
79. Hahn DL: Treatment of Chlamydia pneumoniae infection in adult asthma: A before-after trial. J Fam Pract 41:345-351, 1995
80. Hahn DL, Dodge RW, Golubjatnikov R: Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma. JAMA 266:225-230, 1991
81. Hahn DL, Golubjatnikov R: Asthma and Chlamydial infection: A case series. J Fam Pract 38:589-595, 1994
82. Hall WJ, Hall CB, Speers DM: Respiratory syncytial virus infection in adults: Clinical, virologic, and serial pulmonary function studies. Ann Intern Med 88:203-205, 1978
83. Halsey PB, Albaum MN, Li Y, et al: Do pulmonary radiographic findings at presentation predict mortality in patients with community-acquired pneumonia? Arch Intern Med 156:2206-2212, 1996
84. Hamacher J, Schaberg T: Adhesion molecules in lung disease [abstract]. Lung 172:189-213, 1994
85. Hamilos DL, Young RM, Peter JB, et al: Hypogammaglobulinemia in asthmatic patients. Ann Allergy 68:472-180, 1992
86. Hamory BH, Sande MA, Sydnor A, et al: Etiology and antimicrobial therapy of acute maxillary sinusitis. J Infect Dis 139:197-202, 1979
87. Harford C, Hara M: Pulmonary edema in influenzal pneumonia of the mouse and the relation of fluid in the lung to the inception of pneumococcal pneumonia. J Exp Med 91:245, 1950
88. Henderson FW, Collier AM, Sanyal MA, et al: A longitudinal study of respiratory viruses and bacteria in the etiology of acute otitis media with effusion. N Engl J Med 306:1377-1383, 1982
89. Hendley JO, Gwaltney JM Jr: Mechanisms of transmission of rhinovirus infection. Epidemiol Rev 10:242-258, 1988
90. Hinson KFW, Moon AJ, Plummer NS: Bronchopulmonary aspergillosis. Thorax 7:317-333, 1952
91. Horn MEC, Brain EA, Gregg J, et al: Respiratory viral infection and wheezy bronchitis in childhood. Thorax 34:23-28, 1979
92. Horn MEC, Reed SE, Taylor P: Role of viruses and bacteria in acute wheezy bronchitis in childhood: A study of sputum. Arch Dis Child 54:587-592, 1979
93. Hudgel DW, Langsten L, Seiner JC, et al: Viral and bacterial infections in adults with chronic asthma. Am Rev Respir Dis 120:393-397, 1979
94. Huhti E, Mokka T, Nikoskelainen J, et al: Association of viral and mycoplasma infections with exacerbations of asthma. Ann Allergy 33:145-149, 1974
95. Ida S, Hooks JJ, Siranganian RP, et al: Enhancement of IgE-mediated histamine release from human basophils by viruses. J Exp Med 145:892-896, 1977
96. Isaacs D, Clarke JR, Tyrrell DAJ, et al: Deficiency of production of leukocyte interferon (interferon-α) in vitro and in vivo in children with recurrent respiratory tract infections. Lancet ii:950-952, 1981
97. Jarstrand C, Camner P, Philipson K: Mycoplasma pneumonia and transbronchial clearance. Am Rev Respir Dis 110:415-419, 1974
98. Javorka K, Calkovsk A: The pulmonary surfactant factor. Current knowledge, research trends and use in clinical practice [abstract]. Bratislavske Lokarske Listy 95:452-455, 1994
99. Jenkins CR, Breslin ABX: Upper respiratory tract infections and airway reactivity in normal and asthmatic subjects. Am Rev Respir Dis 130:879-883, 1984
100. Jennings LC, Barns G, Dawson KP: The association of viruses with acute asthma. NZ Med J 100:488-490, 1987
101. Johnston S, Pattemore P, Smith S, et al: Viral infections in exacerbations in school-children with cough and wheeze: A longitudinal study. Am Rev Respir Dis 145:A546, 1992
102. Kaslow JE, Novey HS, Zuch RH, et al: Disseminated strongyloidiasis: An unheralded risk of corticosteroid therapy. J Allergy Clin Immunol 86:138, 1990
103. Kauffman HF, Tomee JFC, Van Der Werf TS, et al: Review of fungus-induced asthmatic reactions. Am J Respir Crit Care Med 151:2109-2116, 1995
104. Kauppinen M, Saikko P: Pneumonia due to Chlamydia pneumoniae: Prevalence, clinical features, diagnosis, and treatment. Clin Infect Dis 21:244-252, 1995
105. Kava T: Acute respiratory infection, influenza vaccination and airway reactivity in asthma. Eur J Respir Dis 150:7-38, 1987
106. Kava T: Effect of respiratory infections on exacerbation of asthma in adult patients. Allergy 41:556-561, 1986
107. Knight V, McClung JW, Wilson SZ, et al: Ribaviran small-particle aerosol treatment of influenza. Lancet 31:945, 1981
108. Koivula I, Sten M, Makela PH: Risk factors in pneumonia in the elderly. Am J Med 96:313-320, 1994
109. Kouradsen HB: Quality and avidity of pneumococcal antibodies before and up to five years after pneumococcal vaccination of elderly patients. Clin Infect Dis 21:616-620, 1995
110. Kuzman I, Soldo I, Schönwald S, et al: Azithromycin for treatment of community-acquired pneumonia caused by legionella pneumophila: A retrospective study. Scand J Infect Dis 27:503-505, 1995
111. LaCroix AZ, Lipson S, Miles TP, et al: Prospective study of pneumonia hospitalizations and mortality of U.S. older people: The role of chronic conditions, health behaviour, and nutritional status. Public Health Rep 104:350-360, 1989
112. Laforce MF: Antimicrobial therapy for lower respiratory tract infections in adults: A review. Clin Infect Dis 14(suppl 2):233-237, 1992
113. Laitinen LA, Heino M, Laitinen A, et al: Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis 131:599-606, 1985
114. Larson E: A causal link between handwashing and risk of infection. Examination of the evidence. Infect Control Hosp Epidemiol 9:28-36, 1988
115. Leitman PS: Fluoroquinolone toxicities - an update. Drugs 49(suppl 2):159-163, 1995
116. Lemanske RF, Dick EC, Swenson CA, et al: Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. J Clin Invest 83:1-10, 1989
117. Lemarchand P, Chinet T, Collignon M, et al: Bronchial clearance of DTPA is increased in acute asthma but not in chronic asthma. Am Rev Respir Dis 145:147-152, 1992
118. Li JTC, O'Connell EJ: Viral infections and asthma. Ann Allergy 59:321-328, 1987
119. Lieberman D, Schlaeffer F, Bolder I, et al: Multiple pathogens in adult patients admitted with community-acquired pneumonia: A one year prospective study of 346 consecutive patients. Thorax 51:179-184, 1996
120. Lipsky BA, Boyko EJ, Inui TS, et al: Risk factors for acquiring pneumococcal infections. Arch Intern Med 146:2179-2185, 1986
121. Little JW, Hall WJ, Douglas RG Jr, et al: Amantadine effect on peripheral airways abnormalities in influenza. A study in 15 students with natural influenza infection. Ann Intern Med 85:117, 1976
122. Lode H, Garau J, Grassi C, et al: Treatment of community-acquired pneumonia: A randomized comparison of sparfloxacin, amoxycillin-davidamic acid and erythromycin. Eur Respir J 8:1999-2007, 1995
123. Lorber B: The common cold. J Gen Intern Med 11:229-236, 1996
124. Mannes GPM, Van Der Heide S, Van Aalderen WMC, et al: Itraconazole allergic bronchopulmonary aspergillosis in twin brothers with cystic fibrosis. Lancet 341:492, 1993
125. Marrie TJ, Durant H, Yates L: Community-acquired pneumonia requiring hospitalization: 5-year prospective study. Rev Infect Dis 11:586-599, 1989
126. Marrie TJ: Today's approach to community-acquired pneumonia. J Respir Dis 14:770-780, 1993
127. Mason EO, Lamberth L, Lichenstein R, et al: Distribution of Streptococcus pneumoniae resistant to penicillin in the USA and in vitro susceptibilities to selected oral antibiotics. J Antimicrob Chemother 36:1043-1048, 1995
128. McClung HW, Knight V, Gilbert BE, et al: Ribaviran aerosol treatment of influenza B virus infection. JAMA 249:2671, 1983
129. McIntosh K, Ellis EF, Hoffman LS, et al: The association of viral and bacterial respiratory infections with exacerbations of wheezing in young asthmatic children. J Pediatr 82:578-590, 1973
130. Mezey RJ, Cohn MA, Fernandez RJ, et al: Mucociliary transport in allergic patients with antigen-induced bronchospasm. Am Rev Respir Dis 118:677-684, 1978
131. Minor TE, Dick EC, DeMeo AN, et al: Viruses as precipitants of asthmatic attacks in children. JAMA 227:292-298, 1974
132. Mitchell I, Inglis H, Simpson H: Viral infections as a precipitant of wheeze in children: Combined home and hospital study. Arch Dis Child 53:106-111, 1978
133. Moine P, Vercken JB, Chevret S, et al: Severe community-acquired pneumonia: Etiology, epidemiology, and prognosis factors. Chest 105:1487-1495, 1994
134. Monteleone CA, Sherman AR: Nutrition and asthma. Arch Intern Med 157:23-34, 1997
135. Monto AS: Viral respiratory infections in the community: Epidemiology, agents, and interventions. Am J Med 99(suppl 6B):24-27, 1995
136. Morice AH, Lai WK: Fatal varicella zoster infection in a severe steroid dependent asthmatic patient receiving methotrexate. Thorax 50:1221-1222, 1995
137. Mossad SB, Mocknum ML, Medendorp SV, et al: Zinc gluconate lozenges for treating the common cold: A randomized, double-blind placebo-controlled study. Ann Intern Med 125:81-88, 1996
138. Musher DM: Pneumococcal pneumonia: Including diagnosis and therapy of infection caused by penicillin-resistant strains. Infect Dis Clin NA 5:509-521, 1991
139. Musher DM, Groover JE, Graviss EH, et al: The lack of association between aging and post-vaccination levels of IgG antibody to capsular polysaccharide of streptococcus pneumoniae. Clin Infect Dis 22:165-167, 1996
140. Musher DM, Groover JE, Rowland JM, et al: Antibody to capsular polysaccharide of streptococcus pneumoniae: prevalance, persistence, and response to revaccination. Clin Infect Dis 17:66-73, 1993
141. Nicholson KG, Kent J, Ireland DC: Respiratory viruses and exacerbations of asthma in adults. British Medical Journal 307:982-986, 1993
142. Niederman MS, Bass JB, Campbell GD, et al: Guidelines for the initial management of adults with community-acquired pneumonia: Diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis 148:1418-1426, 1993
143. Örtqvist Å, Sterner G, Nilsson A: Severe community-acquired pneumonia: Factors influencing need of intensive care treatment and prognosis. Scand J Infect Dis 17:377-386, 1985
144. Pacheco A, Martin JA, Cuevas M, et al: Serologic response to itraconazole in allergic bronchopulmonary aspergillosis. Chest 103:980-981, 1993
145. Palmer LB, Greenberg SE, Schiff MJ: Corticosteroid treatment as a risk factor for invasive aspergillosis in patients with lung disease. Thorax 46:15-20, 1991
146. Pattemore PK, Johnston SL, Bardin PG: Viruses as precipitants of asthma symptoms. Clin Exp Allergy 22:325-336, 1992
147. Patterson R, Samuels BS, Phair JJ, et al: Bronchopulmonary torulopsis. Int Arch Allergy Immunol 69:30-33, 1982
148. Paul S: Catalytic activity of anti-ground state antibodies, antibody subunits, and known autoantibodies [abstract]. Appl Biochem Biotech 47:241-253, 1994
149. Pavia D, Bateman JR, Sheahan NF, et al: Transbronchial mucociliary clearance in asthma: Impairment during remission. Thorax 40:171-175, 1985
150. Peters BS, Thomas B, Marshall B, et al: The role of Chlamydia pneumonia in acute exacerbations in asthma. Am J Respir Crit Care Med 149:A341, 1994
151. Petheram IS, Jones DA, Collins JV: Assessment and management of acute asthma in the elderly: A comparison with younger asthmatics. Postgrad Med J 58:149, 1982
152. Powers DC, Belshe RB: Effect of age on cytotoxic T lymphocytes memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine. J Infect Dis 167:584-592, 1993
153. Quelette JJ, Reed CE: Increased response of asthmatic subjects to methacholine after influenza vaccine. J Allergy 36:558-563, 1965
154. Renwick DS, Connolly MJ: Prevalence and treatment of chronic airways obstruction in adults over the age of 45. Thorax 51:164-168, 1996
155. Riley RL: Airborne infections. Am J Med 57:466-475, 1974
156. Rodrigues J, Niederman MS, Fein AM, et al: Nonresolving pneumonia in steroid-treated patients with obstructive lung disease. Am J Med 93:29-34, 1992
157. Roux N, Flipo RM, Cortet B, et al: Pneumocystis carinii pneumonia in rheumatoid arthritis patients treated with methotrexate. A report of two cases. Rev Rheum Engl Ed 63:453-456, 1996
158. Ruben FL, Dearwater SR, Norden CW, et al: Clinical infections in the noninstitutionalized geriatric age group: Methods utilized and incidence of infections. Am J Epidemiol 141:145-157, 1995
159. Saban R, Dick EC, Fishleder RJ, et al: Enhancement by parainfluenza-3 and capsaicin in airway smooth muscle from guinea pig. Am Rev Respir Dis 136:586, 1987
160. Saikku P, Leinonen M, Tenkanen L, et al: Chronic Chlamydia pneumoniae infection as a risk factor for coronary artery heart disease in the Helsinki study. Ann Intern Med 116:273-278, 1991
161. Saltzman RL, Peterson PK: Immunodeficiency of the elderly. Rev Infect Dis 9:1127-1139, 1987
162. Sbarbaro JA: Compliance with therapy: How great a problem? J Respir Dis 6:44, 1986
163. Schwartz HJ, Greenberger PA: The prevalence of allergic bronchopulmonary aspergillosis in patients with asthma, determined by serologic and radiologic criteria in patients at risk. J Lab Clin Med 117:138-142, 1991
164. Seggev JS, Lis I, Siman-Tov R, et al: Mycoplasma pneumoniae is a frequent cause of exacerbation of bronchial asthma in adults. Ann Allergy 57:263-265, 1986
165. Sen RP, Walsh TE, Fisher W, et al: Pulmonary complications of combination therapy with cyclophosphamide and prednisone. Chest 99:143-146, 1991
166. Shaikh WA: Pulmonary tuberculosis in patients treated with inhaled beclomethasone. Allergy 47:327-330, 1992
167. Shapiro ED, Berg AT, Austrian R, et al: The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 325:1453-1460, 1991
168. Shapiro GG, Eggleston PA, Pierson WE, et al: Double-blind shady of the effectiveness of broad spectrum antibiotic in status asthmaticus. Pediatrics 53:867-872, 1974
169. Silva J: Community-acquired pneumonia: It is time for the penicillin bullet to be replaced. Western J Med 164:79-80, 1996
170. Slavin RC, Cannon RF, Friedman WH, et al: Sinusitis and bronchial asthma. J Allergy Clin Immunol 66:250, 1980
171. Slepian IK, Mathews KP, McLean JA: Aspirin-sensitive asthma. Chest 87:386-391, 1985
172. Sly PD, Hibbert ME: Childhood asthma following hospitalization with acute viral brochiolitis in infancy. Pediatr Pulmonol 7:153-158, 1989
173. Smith DS, Helzner EC, Nuttall CE Jr, et al: Failure of zinc gluconate in treatment of acute upper respiratory tract infections. Antimicrob Agents Chemother 33:646-648, 1989
174. Smith JM: Asthma and atopy as diseases of unknown cause. A viral hypothesis possibly explaining the epidemiologic association of atopic diseases and various forms of asthma. Ann Allergy 72:156-162, 1994
175. Sokhandan M, McFadden ER, Huang YT, et al: The contribution of respiratory viruses to severe exacerbations of asthma in adults. Chest 107(6): 1570-1575, 1995
176. Stefanini M, Allegra S: Pulmonary mucormycosis in acute histiocytic leukemia. N Engl J Med 256:1026, 1957
177. Sterk PJ: Virus-induced airway hyperresponsiveness in man. Eur Respir J 6:894-902, 1993
178. Stollerman GH: Infectious diseases. In Cassel, CK, Cohen HJ, Larson EB, et al: Geriatric Medicine, ed 3, New York, Springer-Verlag, 1997, pp 599-626
179. Szentivanyi A: The beta-adrenergic theory of atopic abnormality in asthma. J Allergy 42:203, 1968
180. Tarlo S, Broder I, Spence L: A prospective study of respiratory infection in adult asthmatics and their normal spouses. Clin Allergy 9:293-301, 1979
181. Thurn JR, Crossley K, Gerdts A: Bacterial colonization of nursing home residents on admission to an acute care hospital. J Hosp Infect 32:127-133, 1996
182. Tipirneni P, Moore BS, Hyde JS, et al: IgE antibodies to mycoplasma pneumoniae in asthma and other atopic diseases. Ann Allergy 45:1-7, 1980
183. Verespej MA, (ed): Wash, wash. Industry Week 246:23, 1997
184. Viladrich PF, Cabellos C, Pallares R, et al: High doses of cefotaxime in treatment of adult meningitis due to Streptococcus pneumoniae with decreased susceptibilities to broad spectrum cephalosporins. Antimicrob Agents Chemother 40:218-220, 1994
185. Wald TG, Shult P, Krause P, et al: A rhinovirus outbreak among residents of a long-term care facility. Ann Intern Med 123:588-593, 1995
186. Walker RC, Wright AJ: The fluoroquinolones. Mayo Clin Proc 66:1249-1259, 1991
187. Wardlaw A, Geddes DM: Allergic bronchopulmonary aspergillosis: A review. J Royal Soc Med 85:747-751, 1992
188. Washing hands fights colds. Parents Magazine 71:50, 1996
189. Weingarten SR, Riedinger MS, Varis G, et al: Identification of low-risk hospitalized patients with pneumonia: Implications for early conversion to oral antimicrobial therapy. Chest 105:1109-1115, 1994
190. Weismann K, Jakobsen JP, Weismann JE, et al: Zinc gluconate lozenges for common cold: A double-blind clinical trial. Dan Med Bull 37:279-281, 1990
191. Welch MJ: Inhaled steroids and severe viral infection. J Asthma 31:43-50, 1994
192. Welliver RC, Wong DT, Sun M, et al: The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N Engl J Med 305:841-846, 1981
193. Whimbey E, Champlin RE, Couch RB, et al: Community respiratory viral infections among hospitalized adult bone marrow transplant recipients. Clin Infect Dis 22:778-782, 1996
194. Wiggins RE Jr: Invasive aspergillosis. A complication of treatment of temporal arteritis. J Neuroophthalmol 15:36-38, 1995
195. Zaia JA: Prevention and treatment of cytomegalovirus pneumonia in transplant recipients. Clin Infect Dis 17(suppl 2):392-399, 1993
196. Ziment I: Management of respiratory problems in the aged. J Am Geriatr Soc 30(suppl 11):36-44, 1982